ArticleCancer research2024

Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer.

Junghui Koo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.